Evidence map›Paper›PMID 37823746›Full record

Observational studyJournal of the American Geriatrics Society2024

Successful aging after elective surgery II: Study cohort description.

Michelle Ward, Tammy T Hshieh, Eva M Schmitt, Steven E Arnold, Michele Cavallari, Bradford C Dickerson, Simon T Dillon, Tamara G Fong, Richard N Jones, Towia A Libermann and 13 more

Abstract readObservational Study
In one paragraph

Observational study in Journal of the American Geriatrics Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Michelle WardDivision of General Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Tammy T HshiehHinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Eva M SchmittHinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Steven E ArnoldHarvard Medical School, Boston, Massachusetts, USA.
Michele CavallariHinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Bradford C DickersonHarvard Medical School, Boston, Massachusetts, USA.
Simon T DillonDepartment of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Tamara G FongHinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Richard N JonesDepartment of Psychiatry and Human Behavior, Department of Neurology, Warren Alpert Medical School, Brown University, Providence, Rhode Island, USA.
Towia A LibermannHarvard Medical School, Boston, Massachusetts, USA.
Alvaro Pascual-LeoneHinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Mouhsin M ShafiHarvard Medical School, Boston, Massachusetts, USA.
Alexandra TouroutoglouHarvard Medical School, Boston, Massachusetts, USA.
Karen WengHinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Guoquan XuHinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Brandon E EarpHarvard Medical School, Boston, Massachusetts, USA.
Lisa KunzeHarvard Medical School, Boston, Massachusetts, USA.
Jeffrey LangeHarvard Medical School, Boston, Massachusetts, USA.
Kamen VlassakovHarvard Medical School, Boston, Massachusetts, USA.
Edward R MarcantonioDivision of General Medicine, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Sharon K InouyeHinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
Thomas G TravisonHinda and Arthur Marcus Institute for Aging Research, Hebrew SeniorLife, Boston, Massachusetts, USA.
SAGES II Study Team

Funding

The Role of Inflammation in the Pathophysiology of Delirium and its Associated Long-Term Cognitive DeclineP01AG031720 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI INOUYE, SHARON K. · 2010 to 2022
$26.7M
TUFTS--FIELDINGP30AG031679 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI SHALENDER BHASIN · 2008 to 2026
$23.9M
READI-SET-GO: Researching Efficient Approaches to Delirium Identification - Sustaining Effective Translation to create Gero-friendly OrganizationsR01AG030618 · NIA · PENNSYLVANIA STATE UNIVERSITY, THE · PI DONNA Marie FICK, EDWARD R MARCANTONIO · 2008 to 2026
$7.9M
Development and Validation of a Delirium Severity ToolkitR01AG044518 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI INOUYE, SHARON K., JONES, RICHARD N · 2014 to 2024
$7.3M
Advancing the Understanding of Postoperative Delirium Mechanisms via Multi-OmicsR01AG051658 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI TOWIA A. LIBERMANN, EDWARD R MARCANTONIO · 2016 to 2026
$5.9M
NIDUS III: Advanced-Stage Development and Utilization of the NIDUS Research Infrastructure to Advance Interdisciplinary Aging Research inDeliriumR33AG071744 · NIA · JOHNS HOPKINS UNIVERSITY · PI John W. Devlin, Esther Seunghee Oh · 2021 to 2026
$4.7M
Mid-Career Mentoring Award for Patient-Oriented Research in AgingK24AG035075 · NIA · BETH ISRAEL DEACONESS MEDICAL CENTER · PI MARCANTONIO, EDWARD R · 2010 to 2021
$1.9M
TMS in Primary Progressive Aphasia: Modulation of Brain Networks and LanguageK23DC016912 · NIDCD · MASSACHUSETTS GENERAL HOSPITAL · PI TOUROUTOGLOU, ALEXANDRA · 2019 to 2023
$871k
Effect of baseline and intercurrent medical factors on 6-year cognitive trajectory: Secondary analysis of the SAGES StudyR03AG075434 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI HSHIEH, TAMMY T · 2022 to 2023
$320k
Delirium and Survival in Post-Acute CareR03AG025262 · NIA · HEBREW REHABILITATION CENTER FOR AGED · PI JONES, RICHARD N · 2005 to 2006
$127k
NIA NIH HHS K24 AG035075NIA NIH HHS K24AG035075NIA NIH HHS P01 AG031720NIA NIH HHS P01AG031720NIA NIH HHS P30AG031679-8440NIA NIH HHS R01 AG030618NIA NIH HHS R01AG030618NIA NIH HHS R01 AG044518NIA NIH HHS R01AG044518NIA NIH HHS R01 AG051658NIA NIH HHS R01AG051658NIA NIH HHS R03 AG025262NIA NIH HHS R03 AG075434NIA NIH HHS R33 AG071744NIA NIH HHS R33AG071744NIDCD NIH HHS K23 DC016912
6 · The paper itself

Abstract

backgroundThe Successful Aging after Elective Surgery (SAGES) II Study was designed to examine the relationship between delirium and Alzheimer's disease and related dementias (AD/ADRD), by capturing novel fluid biomarkers, neuroimaging markers, and neurophysiological measurements. The goal of this paper is to provide the first complete description of the enrolled cohort, which details the baseline characteristics and data completion. We also describe the study modifications necessitated by the COVID-19 pandemic, and lay the foundation for future work using this cohort.

methodsSAGES II is a prospective observational cohort study of community-dwelling adults age 65 and older undergoing major non-cardiac surgery. Participants were assessed preoperatively, throughout hospitalization, and at 1, 2, 6, 12, and 18 months following discharge to assess cognitive and physical functioning. Since participants were enrolled throughout the COVID-19 pandemic, procedural modifications were designed to reduce missing data and allow for high data quality.

resultsAbout 420 participants were enrolled with a mean (standard deviation) age of 73.4 (5.6) years, including 14% minority participants. Eighty-eight percent of participants had either total knee or hip replacements; the most common surgery was total knee replacement with 210 participants (50%). Despite the challenges posed by the COVID-19 pandemic, which required the use of novel procedures such as video assessments, there were minimal missing interviews during hospitalization and up to 1-month follow-up; nearly 90% of enrolled participants completed interviews through 6-month follow-up.

conclusionWhile there are many longitudinal studies of older adults, this study is unique in measuring health outcomes following surgery, along with risk factors for delirium through the application of novel biomarkers-including fluid (plasma and cerebrospinal fluid), imaging, and electrophysiological markers. This paper is the first to describe the characteristics of this unique cohort and the data collected, enabling future work using this novel and important resource.

Indexed as

COVID-19DeliriumAgedAgingBiomarkersHumansPandemicsProspective StudiesBiomarkersbiomarkerscognitive declinecognitive impairmentdeliriumdementialong-term cognitive decline

Identifiers

PMID37823746
PMCPMC10841894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.